These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 792696)

  • 21. Three times a week LAAM equals seven times a week methadone: a preliminary report of a control study. 1974 [proceedings].
    Senay EC; Renault PF; Dimenza S; Collier WE; Daniels SJ; Dorus W
    NIDA Res Monogr; 1976 Jul; (8):90-1. PubMed ID: 792708
    [No Abstract]   [Full Text] [Related]  

  • 22. Addressing the diversion of take-home methadone: LAAM as the sole treatment choice for patients seeking maintenance therapy.
    Hough G; Washton AM; Resnick RB
    NIDA Res Monogr; 1983 Apr; 43():302-9. PubMed ID: 6410265
    [No Abstract]   [Full Text] [Related]  

  • 23. Success and failure of LAAM maintenance: selected case studies.
    Tyler J; Hargreaves WA; Weinberg JA
    J Psychedelic Drugs; 1980; 12(1):41-6. PubMed ID: 7392057
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of clinic attendance schedules for LAAM and methadone: a controlled study.
    Karp-Gelernter E; Savage C; McCabe OL
    Int J Addict; 1982 Jul; 17(5):805-13. PubMed ID: 6752050
    [No Abstract]   [Full Text] [Related]  

  • 25. Current status of the evaluation of LAAM as a maintenance drug for heroin addicts.
    Ling W; Charuvastra VC; Klett CJ
    Am J Drug Alcohol Abuse; 1975; 2(3-4):307-15. PubMed ID: 775968
    [No Abstract]   [Full Text] [Related]  

  • 26. Levomethadyl in maintenance treatment of opiate dependence. 1972 [proceedings].
    Zaks A; Fink M; Freedman AM
    NIDA Res Monogr; 1976 Jul; (8):92-3. PubMed ID: 995185
    [No Abstract]   [Full Text] [Related]  

  • 27. 1-Alpha-acetylmethoadol in the treatment of opiate addiction: progress report. 1971 [proceedings].
    Blachly PH
    NIDA Res Monogr; 1976 Jul; (8):55-6. PubMed ID: 995177
    [No Abstract]   [Full Text] [Related]  

  • 28. LAAM--a long-acting methadone.
    Med Lett Drugs Ther; 1978 Apr; 20(8):40. PubMed ID: 634227
    [No Abstract]   [Full Text] [Related]  

  • 29. Can the community be protected against the hazards of take-home methadone? 1974 [proceedings].
    Goldstein A; Judson B
    NIDA Res Monogr; 1976 Jul; (8):62-3. PubMed ID: 792698
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
    Valdivia JF; Khattak S
    Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA; Bochner F; White JM; Somogyi AA
    Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LAAM and LAAM metabolites: plasma levels in patients. Summary progress report. 1975 [proceedings].
    Goldstein A
    NIDA Res Monogr; 1976 Jul; (8):61. PubMed ID: 995180
    [No Abstract]   [Full Text] [Related]  

  • 34. Uptake and efflux of 1-alpha-acetylmethadol (LAAM) and methadone in the isolated perfused rat lung.
    Roerig DL; Dawson CA; Wang RI
    Drug Metab Dispos; 1982; 10(3):230-5. PubMed ID: 6125355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of LAAM in man: plasma levels of LAAM and its metabolites following acute and chronic administration in man (fourth and sixth quarter progress reports). 1974-5 [proceedings].
    Henderson GL
    NIDA Res Monogr; 1976 Jul; (8):64-5. PubMed ID: 995181
    [No Abstract]   [Full Text] [Related]  

  • 36. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D; Annon J; Anglin MD; Rawson RA
    Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comments on Ritter et al.'s report of a comparative trial of LAAM and methadone maintenance.
    Caplehorn J
    Addiction; 2004 Apr; 99(4):509-10; author reply 510-1. PubMed ID: 15049750
    [No Abstract]   [Full Text] [Related]  

  • 38. Implementing a national study of a new maintenance drug.
    Newmann MC; Klett CJ; Stillman R
    Am J Drug Alcohol Abuse; 1975; 2(3-4):289-300. PubMed ID: 1227292
    [No Abstract]   [Full Text] [Related]  

  • 39. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
    Patricio LD; Miguel N
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
    [No Abstract]   [Full Text] [Related]  

  • 40. (-)-alpha-Acetylmethadol for treatment of chronic pain patients who abuse opioids.
    Tennant FS
    Drug Alcohol Depend; 1983 Nov; 12(3):243-7. PubMed ID: 6140153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.